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Abstract
Background: Ganoderma lucidum-derived polysaccharide (PS-G) can rapidly and effectively promote the activation
and maturation of immature dendritic cells (DCs), suggesting that PS-G possesses the capacity to regulate immune
responses. This study aimed to clarify the immunologic effect of PS-G on monocyte-derived dendritic cells (MD-
DCs) from asthmatic children allergic to house dust mites. The MD-DCs were stimulated for 24 h with the related
allergen, Der p 1, in the presence or absence of PS-G. Cell surface markers and phagocytic capacity were assessed
by FACS analysis, and key polarizing cytokines (IL-12 p40, IL-12 p70, IL-6, IL-23, and IL-10) were quantified. The
subsequent regulatory effect of pulsed MD-DCs on naïve T cells was evaluated by determining the T-cell cytokine
profile.
Results: PS-G induced the maturation of MD-DCs and decreased phagocytic capacity, even if pulsed with Der p 1.
After incubation with PS-G and Der p 1, MD-DCs produced higher amounts of IL-12 p70, IL-12 p40, IL-6, IL-23, and
IL10 than Der p 1-pulsed DCs. Furthermore, type 1 helper T (Th1) cell cytokine (INF-g) production was highly
increased when naïve autologous T cells were co-cultured with Der p 1-pulsed MD-DCs. Naïve T cells stimulated by
MD-DCs pulsed with Der p 1 failed to produce proliferation of T-cells, whereas the addition of PS-G to Der p 1
induced a significant proliferation of T-cells similar to that observed with PS-G alone.
Conclusion: The presence of PS-G in an allergen pulse promoted allergic MD-DCs to produce IL-12 p70, IL-12 p40,
IL-6, IL-23, and IL-10, and exerted an effect on shifting the immune balance towards Th1 in children with allergic
asthma.
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Background
Allergic asthma is a common childhood disease that
often persists into adulthood. The prevalence of child-
hood allergic diseases has increased dramatically in
recent decades in many parts of the world [1], and chil-
dren who mount an immune response to inhalant aller-
gens have an increased risk of developing asthma. This
immune response includes both IgE antibodies and type
2 helper T (Th2) cells, which are thought to contribute
to inflammation in the respiratory tract. Moreover, sen-
sitization to indoor allergens (dust mites, cats, and dogs)
is strongly associated with asthma. The allergic disorders
and diseases are characterized by predominant Th2
cytokine (IL-4, IL-5, and IL-13) production [2].
Ganoderma lucidum, a medicinal mushroom, is among
the most popular herbal medicines in East Asia. G. luci-
dum has been reported to be effective in modulating
immune functions, inhibiting tumor growth, and in the
treatment of chronic hepatopathy, hypertension, neoplasia,
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any medium, provided the original work is properly cited.and hyperglycemia [3-5]. G. lucidum has also been used to
prevent and treat atopic diseases in several mouse and
human models [6-8]. The main functional components of
G. lucidum include polysaccharides, proteins, peptides,
amino acids, and triterpenes. Polysaccharides are well-
known for their immunomodulatory and anti-tumor func-
tions [9] by reportedly enhancing the cytotoxic activity of
natural killer cells and increasing tumor necrosis factor-a
and interferon-g release from macrophages and lympho-
cytes, respectively [10,11]. The polysaccharide component
from G. lucidum (PS-G) has also been reported to elicit
anti-apoptotic effects on neutrophils, which primarily
depend on the activation of Akt-regulated signaling path-
ways [12]. We previously demonstrated that PS-G can
rapidly and effectively promote the activation and matura-
tion of immature healthy human dendritic cells (DCs), and
promote T helper 1 immune responses in mice, thereby
suggesting that PS-G may possess a potential capacity for
regulating immune responses [13,14].
Dendritic cells are powerful antigen-presenting cells, the
primary function which is to capture, process, and present
antigens to naïve T cells [15,16]. Immature DCs reside in
non-lymphoid tissues where DCs can capture and process
antigens. Fully-mature DCs have a high surface expression
of major histocompatibility complex (MHC) class II and
co-stimulatory molecules (CD80 and CD86), but a
decreased capacity to internalize antigens [17]. The induc-
tion of DC maturation is critical for the induction of Ag-
specific T lymphocyte responses and may be essential for
the development of human vaccines relying on T cell
immunity. IL-12 production is also an important marker
for DC maturation and can be used to select Th1-inducing
adjuvants. IL-10, a cytokine that inhibits inflammatory and
cell-mediated immune responses [18], has enormous
potential for treating inflammatory and autoimmune dis-
orders. IL-23, which is mainly produced by macrophages
and DCs [19], was recently identified as a cytokine that
induces IL-17 expression [20]. IL-17 production is
enhanced in acute atopic dermatitis lesions [21] and aller-
gic contact dermatitis [22].
The purpose of the current study was to determine
the potential immune modifications that PS-G directly
affects at the level of DCs in children with allergic
asthma. The development of a defined T-cell profile is
highly dependent on DC-stimulating factors, and the
direct effect of PS-G on allergic MD-DCs may underline
its potential and natural regulatory activity by directing
the development of allergic reactions.
Results
Der p 1-pulsed MD-DCs increased maturation in the
presence of PS-G
MD-DCs displayed a mature cell phenotype similar to
that of LPS-stimulated DCs in the presence of PS-G,
and was characterized by an increase in CD80, CD86,
C D 8 3 ,a n dH L A - D Re x p r e s s i o n( F i g u r e1 )a n da
decrease in the CD1a marker (data not shown). When
PS-G was added to Der p 1-stimulated MD-DCs, the
phenotypic profile was similar to that detected in DCs
stimulated with PS-G alone.
PS-G decreased the endocytotic ability of mature MD-DCs
Immature DCs that capture and process antigens
(through phagocytosis, macro-pinocytosis, and adsorp-
tive endocytosis) lose the ability to take up antigen and
become mature DCs [15]. The uptake of FITC-dextran
has been shown to be maximal in immature human
MD-DCs through macro-pinocytosis and the mannose
receptor [13]. To determine whether or not PS-G mod-
ulates the antigen uptake ability of MD-DCs, FITC-dex-
tran was analyzed by flow cytometry (Figure 2). LPS and
PS-G-treated MD-DCs showed decreased FITC-dextran
uptake compared to untreated control MD-DCs and
MD-DCs treated with Der p 1 alone. However, PS-G
altered the phagocytic capacity of MD-DCs with Der p
1 alone.
PS-G increased IL-12 p70, IL-12 p40, Il-6, IL-23, and IL-10
production by DCs with Der p 1 allergen
Because IL-12, IL-10, IL-6, and IL-23 are known to play key
roles in the modulation of T cell responses [23], IL-12 p70,
IL-12 p40, IL-6, IL-23, and IL-10 produced by MD-DCs
pulsed only with Der p 1, PS-G, or both were evaluated. Der
p 1-pulsed DCs failed to secrete the production of IL-12
p70, IL-12 p40, IL-6, IL-23, and IL-10 in allergic asthmatic
children (Figures 3B, 4B, 5B, 6B, 7B), whereas the reactivity
of DCs to Der p 1 was very weak in allergic patients. In
healthy donors, Der p 1-pulsed DCs produced large
amounts of IL-12 p40 and IL-12 p70 (Figures 3A and 4A).
Interestingly, PS-G increased IL-12 p70 and IL-12 p40
production in Der p 1-pulsed DCs from allergic patients,
while IL-12 p40 levels remained similar to the IL-12 p40
levels obtained in the absence of Der p 1. Moreover, PS-
G induced dose-dependent IL-10 production, which
remained at a similar level in the presence of Der p 1.
PS-G also increased IL-6 and IL-23 production in MD-
DCs pulsed with Der p 1 or PS-G alone. Based on IL-12
p70, IL-6, and IL-10 production, DC reactivity towards
PS-G appeared to be equal in allergic patients and
healthy donors, but there were high levels of IL-12 p40
in healthy donors. Thus, PS-G was shown to induce
DCs from allergic patients to produce the pro-Th1 cyto-
kine IL-12, as observed in healthy donors.
PS-G decreased TH2 cytokine production by CD4-naive
T cells
The polarization of the primary autologous T cells induced
by MD-DCs was then examined. To evaluate the influence
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Page 2 of 10Figure 1 PS-G increased co-stimulatory molecule expression on MD-DCs. Immature MD-DCs were pulsed either with Der p 1 (1 μg/ml) or
PS-G (10 or 25 μg/ml), or both for 24 h and analyzed by flow cytometry for CD80, CD86, CD83, and HLA-DR expression. DCs stimulated with
LPS (100 ng/ml) were positive maturation controls. Values shown are the mean fluorescence intensity (MFI) indexes. Dotted line, isotype control;
solid line, specific mAbs. One representative of three independent experiments is shown.
Figure 2 The effect of PS-G on the phagocytic capacity of MD-DCs. Immature MD-DCs (1 × 10
6 cells/1 ml per well) were incubated for 24 h
either with Der p 1 (1 μg/ml) or PS-G (10 or 25 μg/ml) or both. DCs stimulated with LPS (100 ng/mL) were positive maturation controls. Cells
were then incubated with FITC-dextran for 1 h at 4°C (dotted lines) or 37°C (solid lines). Values shown in the flow cytometry profiles are the MFI
indexes. One representative of three independent experiments is shown.
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Page 3 of 10of PS-G on T-cell polarization, Der p 1-pulsed MD-DCs
incubated with or without PS-G were further co-cultured
with autogeneic naïve CD4
+ T cells. The production of
Th1 cytokines (IFN-g), Th17 cytokines (IL-17A), and Th2
cytokines (IL-4, IL13, and IL-5) were analyzed.
Stimulation of naïve T cells from allergic patients with
D C sp u l s e do n l yw i t hP S - G ,n o to n l yD e rp1 ,i n d u c e d
high IFN-g production. The addition of PS-G to the Der p
stimulus significantly modified IFN-g secretion (Figure 8A).
When autologous naïve CD4
+T cells from allergic asth-
matic children were incubated with Der p 1-pulsed DCs,
production of IL-5 was observed; however, this production
was significantly decreased in Der p 1-pulsed DCs with
PS-G (Figure 8B). The production of IL-4, IL-13, and
IL-17A were not significantly changed (data not shown).
PS-G induced T-cell proliferation by Der p 1-pulsed
MD-DCs
When naïve CD4
+ T cells were co-cultured for 3 days
with Der p 1-pulsed MD-DCs from children with aller-
gic asthma, the proliferation of T cells was low com-
pared to unpulsed DCs (Figure 9). The addition of PS-G
to Der p 1 induced a significant proliferation of T-cells
similar to that observed with PS-G alone.
Figure 3 PS-G increased IL-12 p40 production in Der p
1-pulsed MD-DCs from five healthy children (A) and six
children with allergic asthma (B). MD-DCs were incubated for
24 h with Der p 1, PS-G, or both. The supernatants were collected
for cytokines. Data are represented as the mean ± SE for three
determinations. Statistical analysis focused on DCs with or without
PS-G in the presence of Der p 1. *p < 0.05. (Cont = control)
Figure 4 PS-G increased IL-12 p70 production in Der p
1-pulsed MD-DCs from five healthy children (A) and six
children with allergic asthma (B). MD-DCs were incubated for
24 h with Der p 1, PS-G, or both. The supernatants were collected
for cytokines. Data are represented as the mean ± SE for three
determinations. Statistical analysis focused on DCs with or without
PS-G in the presence of Der p 1. *p < 0.05. (Cont = control)
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Ganoderma lucidum (G. lucidum: Lingzhi in Chinese,
Reishi in Japanese) has been used for a long time in
China and other Asian countries to prevent and treat
various human diseases. Ganoderma lucidum has been
the subject of modern pharmacologic and clinical
research in the last 30 years, and is reportedly effective
in promoting health and longevity, and enhancing the
efficacy of treatment of many diseases. The main aim of
this study was to determine the regulatory effect of PS-
G on MD-DCs from children with allergic asthma. The
results showed that PS-G increased the expression of
CD80, CD86, CD83, and HLA-DR molecules on the cell
m e m b r a n e so fD e rp1 - p u l s e dM D - D C s .E v e nt h o u g h
the maturation markers of MD-DCs from children with
allergic asthma treated with PS-G alone increased, the
effect was as clear as the effect in MD-DCs treated with
LPS alone. Taken together, PS-G or LPS alone induces
the maturation of MD-DCs from allergic asthma
patients, and LPS- and PS-G-treated MD-DCs showed
decreased antigen processing compared to control MD-
DCs and MD-DCs treated with Der p 1 alone.
We also evaluated the production of cytokines (IL-12
p40, IL-12 p70, IL-6, IL-23, and IL-10) in MD-DCs from
Figure 5 PS-G increased IL-6 production in Der p 1-pulsed
MD-DCs from five healthy children (A) and six children with
allergic asthma (B). MD-DCs were incubated for 24 h with Der p 1,
PS-G, or both. The supernatants were collected for cytokines. Data
are represented as the mean ± SE for three determinations.
Statistical analysis focused on DCs with or without PS-G in the
presence of Der p 1. *p < 0.05. (Cont = control)
Figure 6 PS-G increased IL-23 production in Der p 1-pulsed
MD-DCs from five healthy children (A) and six children with
allergic asthma (B). MD-DCs were incubated for 24 h with Der p 1,
PS-G, or both. The supernatants were collected for cytokines. Data
are represented as the mean ± SE for three determinations.
Statistical analysis focused on DCs with or without PS-G in the
presence of Der p 1. *p < 0.05. (Cont = control)
Jan et al. BMC Immunology 2011, 12:31
http://www.biomedcentral.com/1471-2172/12/31
Page 5 of 10allergic asthma children, and found that PS-G alone sti-
mulated Der p 1-pulsed DCs to secrete IL-12 p40, IL-12
p70, IL6, IL23, and IL-10. The different responses of PS-G
on DCs from healthy and allergic donors are particularly
noteworthy. PS-G induced a large amount of IL-12 p40
from healthy compared to atopic donors. IL-12 is a het-
erodimeric cytokine produced by activated macrophages,
neutrophils, and dendritic cells. Endogenous IL-12p40
selectively inhibits AHR and airway remodeling in an
asthma model with prolonged antigen exposure [24].
IL-12B is located in this genomic region and encodes
IL-12p40 [25]; however, the allelic effects of this poly-
morphism on asthma susceptibility and asthma-related
phenotypes has been shown. The first report suggested
that the heterozygous genotype was more frequently
detected in children with severe asthma [26]. The genetic
variation in the promoter of IL-12B displays functional
activity and cytokine production capacity.
We also showed that the amount of IL-23 produced
by PS-G on DCs from healthy donors was higher than
allergic donors (Figure 3D). The p40 subunit of IL-12 is
Figure 7 PS-G increased IL-10 production in Der p 1-pulsed
MD-DCs from five healthy children (A) and six children with
allergic asthma (B). MD-DCs were incubated for 24 h with Der p 1,
PS-G, or both. The supernatants were collected for cytokines. Data
are represented as the mean ± SE for three determinations.
Statistical analysis focused on DCs with or without PS-G in the
presence of Der p 1. *p < 0.05. (Cont = control)
Figure 8 PS-G affected T cell cytokine response.M D - D C sf r o m
five children with allergic asthma were pulsed with Der p, PS-G, or
both for 24 h and cultured with autogenic naïve T cell.
Supernatants were analyzed for IFN-g (A) and IL5 (B), which were
produced by activated T cells after 2 days of culture. Data are
represented as means ± SEM of triplicates and representative of
three independent experiments. Statistical analysis focused on DCs
with or without PS-G in the presence of Der p 1. *p < 0.05. (Cont =
control)
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distinct from IL-12 [27]. A protective role for the Th1
response generated by IL-12/IL-23 has been suggested
based on infectious diseases in children with genetic
defects of the IL-12/23 - IFN-g circuit [28].
PS-G-induced IL-12 p40 and IL-12 p70 secretion, and
shifted the immune balance towards Th1. The data pre-
sented also shows that PS-G induces IL-10 secretion.
Recent observations indicate that DCs play an important
roles in activating regulatory T (Treg) cells, including
induction of CD4
+ T cells into Foxp3
+ Treg cells
in vitro [29], IL-10-producing CD4+ Treg cells [30], and
regulating the balance of Th1/Th2 immunity [31].
Cytokines are involved in orchestrating the initiation
and maintenance of allergic inflammatory responses.
Th2 cytokines, such as IL-4, IL-5, and IL-13, are
involved in the development and maintenance of the
allergic immune response.T h eT h 1c y t o k i n e ,I F N - g,i s
known to down-regulate Th2 responses by antagonizing
IL-4. The selective production of IFN-g is tightly regu-
lated and is highly dependent on the reactivity of DCs
to the environment, which in turn contributes to the
T-cell polarization process. PS-G increases IL-6 and
I L - 2 3p r o d u c t i o ni nD C s ,a l t h o u g hI L - 6a n dI L - 2 3
appear to play a role in the induction of IL-17 by
human CD4+ T cells, IL-1b, and TGF-b, in combination
with other factors, which are essential in the induction
of IL-17 production [23]. Thus, the production of
IL-17A by the stimulation of naïve T cells with DCs pulsed
with PS-G, was not significantly changed in this study.
Th17 cytokines have been shown to have an associa-
tion with allergic disease. Th17 cells are highly involved
in the development and maintenance of psoriasis [32],
and a possible role for IL-17, IL-22, and Th17 cells in
atopic dermatitis or allergic contact dermatitis is emer-
ging. Nickel-specific Th0, Th1, or Th2 clones from aller-
gic contact dermatitis patients have been shown to
produce IL-17 [33]. Elevated IL-17 concentrations have
also been found in lung and blood of allergic asthma
patients and has been linked to the severity of asthma
[34,35]. Whether or not a specific role exists for Th17
cells in asthma, however, is controversial [36].
This is the first study to demonstrate that PS-G
induces the production of Th1 cytokines produced by
naïve human T cells through a direct effect on DCs in a
model of children with allergic asthma. These results
extend our previous findings that PS-G can induce gene
expression changes in human DCs, and specifically pro-
m o t eT h 1c y t o k i n er e l e a s ei nB A L B / cm i c e[ 1 4 ] .O t h e r
studies have reported on the immunomodulatory and
adjuvant activities of PS-G in mice [37,38].
The cytokine environment encountered by a naïve
CD4
+T cell plays a prominent role in determining
w h e t h e ro rn o tn a ï v eC D 4
+ T cells develop into Th1
or Th2 cells. Thus, the same naïve CD4
+Tc e l l sc a n
give rise to Th1 or Th2 cells under the influence of
environmental (e.g., cytokine) and genetic factors.
IFN-g production is related to an increase in IL-12
p40 and IL-12 p70 production observed when MD-
DCs from children with allergic asthma are pulsed by
Der p 1 in the presence of PS-G. Taken together, we
suggest DCs may be the key cell type in children with
allergic asthma.
IL-12 also has an important function in promoting
Th1 immune responses and limiting the establishment
and maintenance of Th2-type responses, mainly by
enhancing IFN-g production and by providing an effec-
tive deviation signal during the early differentiation of
Th0 cells [39]. Thus, IL-12 p40 and IL-12 p70 produc-
tion by PS-G may contribute to switching the balance
from an established Th2 response to a more pro-
nounced Th1 response.
Attempts to evaluate the effect of PS-G on specific T-
cell proliferation in allergic asthmatic children has led to
an apparent dichotomy for naïve T cells. Whereas naïve
T cells exhibit a weak proliferative response to Der p 1-
pulsed DCs, increased T cell proliferation is observed
with PS-G-treated MD-DCs. T-cell proliferation requires
at least two signals, one through contact of antigen-
MHC with T cell receptors and the other through an
interaction between co-stimulatory molecules [40,41].
Thus, the varying degrees of DC maturation may explain
Figure 9 PS-G affected T cell proliferation response. MD-DCs
from five children with allergic asthma were pulsed with Der p, PS-
G, or both for 24 h and cultured with autogenic naïve T cell.
Autologous T-cell proliferation was measured after 3 days of co-
culture with MD-DC. The stimulation index (SI) was calculated as a
mean counts per minute (cpm) of stimulated wells divided by the
mean cpm of control wells. Values are presented as the mean
stimulation index for triplicate wells. Data are represented as the
mean ± SE of five determinations. Statistical analysis focused on
DCs with or without PS-G in the presence of Der p 1. *p < 0.05.
(Cont = control)
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lactic acid bacteria have been shown to have roles in
modulating DC maturation from allergic patients [42].
Indeed, in response to Der p 1, DCs express quite low
levels of co-stimulatory molecules compared to PS-G-
pulsed DCs, which express intense up-regulation of the
surface markers (i.e., CD80, CD83, CD86, and HLA-
DR). There is an apparent relationship between the
emergence of the PS-G-dependent T cell population and
the increase in IFN-g production.
Conclusion
The results suggest that PS-G may switch the estab-
lished Th2 response in allergic patients towards a long-
lasting Th1 response, and may therefore represent a
new therapeutic strategy for the treatment of children
with allergic asthma.
Methods
Patients
Blood was collected from allergic patients sensitive to
Dermatophagoides pteronyssinus and from non-atopic
healthy children. All allergic children had a history of
asthma and presented with the usual features of house
dust mite sensitization, as follows: specific IgE antibo-
dies (CAP class >3); and positive skin prick test
responses to D. pteronyssinus. The total IgE level was
>250 kU/L. The Research Ethics Committee of Hualien
Tzu-Chi General Hospital approved the study and all
subjects provided informed consent.
PS-G purification from G. lucidum
As we previously reported [4], fruiting bodies of G. luci-
dum were washed, disintegrated, and extracted with boil-
ing water for 8-12 h. The hot water extract was
fractionated into a polysaccharide fraction (alcohol insolu-
ble) and non-polysaccharide fraction (alcohol soluble). The
crude polysaccharide obtained was then passed through a
gel-filtration Sephadex G 50 column (Pharmacia, Uppsala,
Sweden) and further purified by anion exchange chroma-
tography with diethylaminoethyl-cellulose [3].
The polysaccharide from Ganoderma lucidum (PS-G)
is a branched (1®6)-b-D-glucan moiety. To rule out
possible endotoxin lipopolysaccharide (LPS) contamina-
tion, the LPS content was determined by the chromo-
genic Limulus Amebocyte Lysate assay, which showed
no detectable levels of endotoxin (<0.10 endotoxin
units/ml) in the PS-G samples.
Human DC generation
The DCs were generated from peripheral mononuclear
cells (PBMCs), as described previously [43,44],
but with some modifications. Briefly, PBMCs were
obtained from donors by Ficoll-Hypaque centrifugation
(PharmaciaSweden). The light density fraction from
the 42.5%-50% interface was recovered. CD14
+ cells
were purified by positive selection using anti-CD14
+
micro-beads in conjunction with a MiniMACS system,
following the manufacturer’s instructions (Miltenyi
Biotech, Auborn, CA, USA). The DC14
+ cells were cul-
t u r e da t1×1 0
6 cells/ml of cRPMI in 24-well plates
(Costar) with GM-CSF (800 U/ml) and IL-4 (500 U/
ml). Fresh medium containing GM-CSF and IL-4 was
added every 2-3 days. Human monocyte-derived DCs
were routinely used on day 6 of culture.
Activation of DCs
The MD-DCs (1 × 10
6 cells/1 ml per well) were incu-
bated for 24 h with Der p 1 (1 μg/ml) or PS-G (10 or
25 μg/ml) or both. As a positive maturation control,
DCs were stimulated with LPS (100 ng/ml). Escherichia
coli LPS (L8274) was purchased from Sigma-Aldrich
Chemical Co. (St. Louis, MO, USA).
Flow cytometric analysis for surface markers
The DCs were harvested and washed with cold buffer
(PBS containing 2% FCS and 0.1% sodium azide), incu-
bated in cold buffer, and subsequently stained with
FITC- or PE-labeled mAbs (anti-human CD86, CD80,
CD83, HLA-DR or relevant isotype controls; BD Phar-
mingen) (Becton Dickinson, San Jose, CA) based on the
manufacturer’s instructions. The DC surface marker
expression was analyzed using the CellQuest program,
which excluded dead cells.
Phagocytic capacity analysis
The MD-DCs were washed twice, re-suspended in 1 ml
of RPMI 1640 medium containing 10% FCS, and placed
on ice for 30 min. The cells were then incubated with
FITC-labeled dextran (0.2 mg/ml; Invitrogen, Carlsbad,
CA, USA) at 4°C or 37°C for 1 h. Finally, the cells were
thrice-washed with cold buffer and analyzed with a
FACSort cell analyzer.
Autologous mixed leukocyte reaction (MLR)
The PBMCs were obtained as described above and naïve
CD4
+T cells were purified from PBMCs using magnetic
beads (Miltenyi Biotec). The autologous naïve CD4
+T
cells were distributed at 1 × 10
6 cells per well and incu-
b a t e df o r5d a y si nt h ep r e s e n c eo f1×1 0
5 stimulated
MD-DCs. Tritiated thymidine (1 μCi/well; New England
Nuclear, Boston, MA, USA) incorporation for 16 h was
determined using a liquid scintillation counter.
Cytokine assay
DC activation
After a 24-h stimulation in the 4 conditions (non-pulsed
or pulsed with Der p 1, PS-G, or Der p 1 plus PS-G),
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6)w e r ec o l -
lected, centrifuged, and tested via ELISA (R&D Systems,
Minneapolis, MN, USA) for the presence of IL-6, IL-23,
IL-10, IL-12 p70, and IL-12 p40.
T cell-DC co-cultures
After washing, 1 × 10
5 stimulated MD-DCs were incu-
bated with 1 × 10
6 naïve CD4
+T cells for 2 days. The
co-cultures were performed in 48-well, flat-bottomed
culture plates (1 ml/well). The presence of IL-13, IL-
17A, IL-4, IL-5, and IFN-g in the supernatants was
detected by means of ELISA (R&D Systems).
Statistical analysis
Parametric statistical analysis was performed with the
Student’s test, and a p < 0.05 was considered statistically
significant.
Abbreviations
PS-G: Ganoderma lucidum; DCs: dendritic cells; Th1: helper T type 1; IFN-γ:
interferon-γ; LPS: lipopolysaccharides
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